Clinical Trials Directory

Trials / Recruiting

RecruitingNCT03299569

Establishing the Incidence of Tako-tsubo Cardiomyopathy in Scotland

Establishing the Incidence of Tako-tsubo Cardiomyopathy in Scotland - the STARR Study

Status
Recruiting
Phase
Study type
Observational
Enrollment
800 (estimated)
Sponsor
University of Aberdeen · Academic / Other
Sex
All
Age
Healthy volunteers

Summary

Acute stress-induced (Takotsubo cardiomyopathy) presents like a heart attack and is triggered by intense emotional or physical stress. Although coronary arteries are unobstructed, it has been suggested that the risk of death is similar to a myocardial infarction. The purpose of the STARR study is to identify all cases of Takotsubo in Scotland since 2010 and assess its epidemiology and outcomes.

Detailed description

Public Health Scotland will identify all patients centrally coded under codes I42.8 (Other cardiomyopathies), I42.9 (Cardiomyopathy, unspecified) and I51.8 (Other ill-defined heart diseases), using the Community Health Index (CHI) numbers from January 2010. All identified CHI numbers will be thereafter cross-checked with their clinical data at participating health boards to confirm a diagnosis of takotsubo cardiomyopathy and a registry of all confirmed Takotsubo cases will be established. Clinical data will be collected for all Takotsubo patients retrospectively and prospectively. This will be compared to two contemporaneous gender and age matched control populations: 1. a cohort of randomly selected individuals from the Scottish general population supplied by Public Health Scotland 2. patients with myocardial infarction (extracted through collaboration with, the High-STEACS investigators, NCT01852123). Electronic data linkage will be performed by Public Health Scotland to assess outcomes, prescribing and scores of prediction.

Conditions

Timeline

Start date
2016-07-29
Primary completion
2028-12-31
Completion
2028-12-31
First posted
2017-10-03
Last updated
2025-03-24

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT03299569. Inclusion in this directory is not an endorsement.